Press Releases | Recent Articles


June 22, 2020

Canon Medical Systems Corporation has agreed on establishing a joint venture with leading Russian healthcare provider, R-Pharm Holding, LLC, for sales and maintenance of diagnostic imaging equipment manufactured by Canon Medical in nine CIS member states, including Russia, and will consummate the joint venture when all the necessary regulatory approvals are obtained.


May 7, 2020

TOKYO, May 7,2020—As part of Canon Inc.’s global medical business strategic realignment, in order to take advantage of medical imaging company expertise and business synergies, the eye care business operations within Canon (China) Co., Ltd. has been transferred to Canon Medical Systems (China) Co., Ltd. (hereinafter referred to as Canon Medical China) effective May 1, 2020.


March 26, 2020

Canon Medical Systems Corporation, working together with Nagasaki University, has completed development of Genelyzer KIT, a set of reagents for SARS-CoV-2 RNA testing based on a gene amplification technique known as the fluorescent LAMP method.


March 19, 2020

Canon Medical Systems Corporation has begun research into the practical application of a new rapid genetic testing system for the novel coronavirus (SARS-CoV-2) which is being developed by Canon Medical Systems Corporation in cooperation with Nagasaki University.


February 25, 2020

Ohtawara, Japan; February 26 Canon Medical Systems Corporation (Canon Medical) announces the start of development of a rapid genetic testing system for the novel coronavirus (COVID-19) reaffirming the company’s commitment to the basic research and development of rapid diagnostic test kits.


January 30, 2020

Canon (China) Co., Ltd., Canon Medical Systems (China) Co., Ltd. and all members of the Canon Group, via the National Health Commission of the People’s Republic of China, will donate a full-body X-ray CT diagnosis system to the Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, in the city of Wuhan.


December 10, 2019

As part of Canon Inc.’s global medical business strategic realignment, the eye care business operations within Canon U.S.A., Inc. will transfer to Canon Medical Systems USA, Inc. effective January 1, 2020.


December 3, 2019

As part of Canon Inc.’s global medical business strategic realignment, the X-ray business operations within U.S.A., Inc.’s wholly owned subsidiary Virtual Imaging, Inc. will transfer to Canon Medical Systems USA, Inc. (CMSU) effective January 1, 2020.


November 25, 2019

Canon Medical Systems Corporation has concluded a contract to acquire all shares of Skope Magnetic Resonance Technologies AG.


October 14, 2019

Canon Medical Systems Corporation  is pleased to announce the official opening of its Middle East Division in  Canon Middle East Dubai, UAE. Preparations are now underway to start business operations around the beginning of January 2020.


September 10, 2019

Canon Medical Systems Corporation (Canon Medical) announces completion of an agreement with US-based FemtoDx, Inc. (FemtoDx) relating to a capital investment based on stock purchase.


August 1, 2019

Canon Inc. (Headquarters: Ohta-ku, Tokyo, Japan; Chairman and CEO: Fujio Mitarai) Canon Medical Systems Corporation (“Canon Medical”; Headquarters: Tochigi Prefecture, Japan; President: Toshio Takiguchi) and the Center for iPS Cell Research and Application, Kyoto University (“CiRA”; Headquarters: Sakyo-ku, Kyoto, Japan; Director: Shinya Yamanaka) announced today that the parties have agreed to commence joint research from August 1, 2019, with the aim of contributing to the field of regenerative medicine through the realization of higher-quality induced pluripotent stem (iPS) cells1 for autograft purposes, or “my iPS cells2.”


July 1, 2019

Canon Medical Systems Corporation (Headquarters: Otawara, Tochigi Prefecture, Japan; President and CEO: Toshio Takiguchi) has agreed to establish a framework with R-Pharm Holding (a part of R-Pharm Group, headquarters: Moscow, Russia; Chairman and President: Alexey Repik), a leader of Russian healthcare market, to promote sales of diagnostic imaging systems manufactured by Canon Medical Systems, and to localize Canon’s medical equipment production at R-Pharm’s facilities in Russia.


May 16, 2019

Otawara, Japan; May 16, 2019- Canon Medical Systems Corporation (Canon Medical) will present Deep Learning Reconstruction (DLR) technology at the International Society for Magnetic Resonance in Medicine (ISMRM) 2019 Annual meeting in Montreal, Vancouver.


January 30, 2019

January 28, 2019; Otawara, Japan – Canon Medical Systems Corporation (Canon Medical) introduces Global Illumination rendering technology within the Vitrea® platform. This technology allows physicians to interact in real-time with photorealistic images and visualize patient anatomy in all dimensions.


January 28, 2019

Canon Medical Systems Corporation (Canon Medical) to launch new Aquilion Start CT system at Arab Health in Dubai, United Arab Emirates from 28 -31 January, 2019.


November 20, 2018

Canon Medical Systems Corporation and Ichiban S.A. de Inversión reached an agreement on the conditions for transferring the assets related to the distributor business of GRIENSU S.A. to Canon Medical Systems Argentina S.A. on August 7, 2018 (local time).


November 15, 2018

Canon Medical Systems Corporation has agreed to subscribe to a third-party allotment from LPixel Inc.


October 20, 2018

October 20, 2018: Under their new company name Canon Medical will be Diamond sponsor of the ISUOG World Congress and host a four-day program of educational activities, including insight sessions, satellite symposium and live scans. Key opinion leaders in maternal fetal medicine have been invited to share their experiences and demonstrate the clinical value of Canon’s imaging technologies.


June 14, 2018

Canon Medical Systems Corporation (Canon Medical) announces the showcasing of a new Ultra-High Resolution research-enabled 3T MRI System, representing the latest addition to its Magnetic Resonance Imaging portfolio, at the ISMRM-ESMRMB 2018 Joint Annual Meeting in Paris, France.

Contact Us